Biocon Biologics settles patent issue; paves way for launch of biosimilar product in CanadaBiocon Biologics has settled patent disputes with Bayer Inc and Regeneron Pharmaceuticals Inc, enabling the launch of Yesafili, an ophthalm...
04 Mar, 2024, 11.47 AM IST
Innovation is key to sustainable transformation: Werner Baumann, CEO, Bayer AG"Innovation and collaboration are key to sustainable transformation. But if you look specifically at the “how” of transformation in a compa...
10 May, 2022, 02.33 PM IST
Recursion Pharmaceuticals expands IPO to raise $436 millionThe Salt Lake City-based company sold about 24 million shares on Thursday for $18 each, according to data compiled by Bloomberg. The compan...
16 Apr, 2021, 09.48 AM IST
Bayer to acquire Asklepios Bio in foray into gene therapy worth up to $4 billionGermany’s Bayer will pay $2 billion upfront and up to an additional $2 billion in milestone payments contingent on development achievements...
26 Oct, 2020, 01.14 PM IST
Big pharma returning to US price hikes in January after pausePfizer has already announced plans to hike prices on 41 of its drugs in mid-January.
20 Dec, 2018, 01.26 PM IST
How this $66 billion deal turned ‘oracle’ Warren Buffett into an arbitragerWe don't know for sure if it was Buffett himself or one of his stock-picking deputies who made the investment. Either way, he no doubt gave...
15 Feb, 2017, 12.13 PM IST
Natco Pharma's partner MylanInc gets USFDA nod for cancer drugThe company's marketing partner Mylan Inc has received a tentative approval from the United States Food and Drug Administration (USFDA).
03 Jun, 2016, 02.52 PM IST
Germany’s Bayer exploring takeover bid for MonsantoThe German firm has held preliminary discussions internally and with advisers about buying Monsanto, which has a market value of almost $40...
13 May, 2016, 02.32 AM IST
Natco Pharma's US partner Mylan files application with USFDANatco Pharma's marketing partner Mylan Inc has filed an application with the US health regulator for generic Sorafenib tablets used mainly ...
11 Feb, 2015, 10.53 PM IST
Fulford India divests consumer care biz to Bayer Pharmaceuticals Private LtdBayer will completely take over the marketing and distribution of the consumer care products with effect from January 1, 2015, it added.
23 Dec, 2014, 07.46 PM IST
Bayer to focus on life science business, spin off polymer divisionThe aim would be to continue the positive development of these activities in the future through further investment in growth, the statement...
19 Sep, 2014, 09.06 PM IST
Lupin launches generic Ciprofloxacin in US marketThe company had earlier received final approval for the product from the United States Food and Drug Administration (USFDA), it added.
13 Jun, 2014, 04.26 PM IST
Lupin gets USFDA approval for oral contraceptive tabletsLupin today said it has received US health regulator's approval to market Drospirenone and Ethinyl Estradiol Tablets, an oral contraceptive...
19 Dec, 2012, 05.37 PM IST
Pfizer to appeal India decision to revoke cancer drug patentPfizer Ltd, the India unit of US drugmaker Pfizer Inc, will challenge the country's patent office for revoking a patent for its cancer drug...
05 Oct, 2012, 01.04 PM IST
- Zydus Cadila Q1 net up 15.38% at Rs 229.82 crore
Ahmedabad-based Zydus Cadila today said its consolidated net profit rose by 15.38 per cent to Rs 229.82 crore in the first quarter ended Ju...
19 Jul, 2011, 04.30 PM IST
- Natco may seek compulsory licence for Bayer's cancer drug
Natco Pharma plans to seek a compulsory licence to make Bayer AG's Nexavar in India, invoking a provision in local laws that allows generic...
24 Jan, 2011, 06.18 AM IST
- Pfizer’s growth outlook seen strong
The Pfizer stock has offered better returns to investors than the Bombay Stock Exchange’s (BSE) benchmark index, the Sensex, over the past ...
14 Jul, 2010, 02.11 AM IST